ニュースルーム
01
02
03
04
05
01
/
05
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
Repligen Corporation yoday announced the commercial launch of TangenX® SC, the industry’s first holder-free, self-contained Tangential Flow Filtration (TFF) device.The technology is especially suited to the manufacture of biologics where fully closed systems are critical or ideal.
Repligen completes the acquisition of Metenova
Repligen acquired Metenova, a leading Swedish innovator in magnetic mixing technology for biopharmaceutical production. This strategic step further strengthens Repligen's Fluid Management franchise, enriching our single-use mixing solutions and expanding our product range. Welcome, Metenova!
Repligen acquires FlexBiosys Inc.
Repligen today entered an agreement to acquire FlexBiosys Inc. of Branchburg, NJ. The acquisition is another step in building out Repligen’s Fluid Management franchise, adding a full range of single-use bioprocessing bags and assemblies to our product offering. The addition of FlexBiosys complements and vertically integrates our systems offering, providing a more complete single-use fluid management portfolio of products for our biopharmaceutical manufacturing customers. Welcome FlexBiosys!
KrosFlo® KR2i RPM™システムの導入
新しいKrosFlo KR2i RPMシステムを使用して、UF/DF実行中の濃度を監視します。インラインタンパク質濃度管理により、KrosFlo KR2i TFFシステムの能力とCTech™ FlowVPX®システムの情報を利用してプロセスを制御できます。
プロセス分析の拡張：Daylight Solutions
Repligenは、Culpeo®の商品化、およびバイオプロセシング市場の急成長しているプロセス分析技術（PAT）部門における未来の製品および技術の開発を引き受けます。